Journal of Oncology Pharmacy Practice

作者署名政策说明署名标准、通讯作者人选等事项，并明确指出AI聊天机器人（例如ChatGPT）不应被列为作者。 模型中文摘要

Please view our authorship policies, which includes information on criteria for authorship, who should be the corresponding author and more. Please note that AI chatbots, for example ChatGPT, should not be listed as authors. For more information see the policy on Use of ChatGPT and generative AI tools.

数据可用性政策鼓励作者在符合伦理与法律要求的前提下，将研究数据存入相关公共数据仓库、提供链接数据的数据可用性声明（无法共享时说明原因）并在研究中引用该数据。 模型中文摘要

The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…

伦理政策要求在指定标题下提供伦理批准声明（即使方法部分已写明），未获伦理批准要求时须明确说明；涉及人类参与者、人类数据或人体组织的研究必须声明相关伦理委员会或机构审查委员会批准或豁免，并提供委员会全名、所属机构及批准编号。 模型中文摘要

Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…

开放获取政策说明向本刊投稿或发表无需支付任何费用，可选择通过Sage Choice计划或开放获取协议付费（或按协议折扣或免费）进行开放获取出版，协议资格取决于通讯作者所属机构在录用时匹配相应协议。 模型中文摘要

There are no fees payable to submit or publish in this journal. Optional open access publishing is available for a fee via the Sage Choice program, and Open Access agreements, where authors can publish open access either discounted or free of charge depending on the agreement with Sage. Find out if your institution is participating by visiting Open Access Agreements at Sage. Open Access agreement …

同行评审政策说明本刊采用双匿名评审，评审人与编辑互动且不公布评审信息；稿件先经初步评估，不符合指南将被退回修改，超出范围或不合适的稿件可能未经评审即被拒稿，通过初评后进入同行评审。 模型中文摘要

The following summary describes the peer review process for this journal: Identity transparency: Double-anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…

抄袭政策表明期刊和Sage严肃对待版权侵犯、抄袭或其他违反出版最佳实践的行为，并请作者阅读Sage完整的抄袭政策及可能采取的措施。 模型中文摘要

The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.

预印本政策说明本刊接受已在预印本服务器发布的稿件，投稿时须在指定字段填写预印本DOI并告知编辑部，且同行评审期间不应在预印本服务器发布更新版本。 模型中文摘要

The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…

临床试验注册政策要求临床试验在首个受试者入组时或之前在WHO认可的公共试验注册机构注册，作为发表考虑的条件，并须在摘要末尾提供注册机构名称、网址和注册号。 模型中文摘要

The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.